Funderburg, N. T., Xu, D., Playford, M. P., Joshi, A. A., Andrade, A., Kuritzkes, D. R., . . . Mehta, N. N. (2016). Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity. Antivir Ther.

Funderburg, Nicholas T., Dihua Xu, Martin P. Playford, Aditya A. Joshi, Adriana Andrade, Daniel R. Kuritzkes, Michael M. Lederman, et Nehal N. Mehta. "Treatment of HIV Infection With a Raltegravir-based Regimen Increases LDL Levels, but Improves HDL Cholesterol Efflux Capacity." Antivir Ther 2016.

Funderburg, Nicholas T., et al. "Treatment of HIV Infection With a Raltegravir-based Regimen Increases LDL Levels, but Improves HDL Cholesterol Efflux Capacity." Antivir Ther 2016.